Dr. Thomas Marshall Aaberg Jr., MD

Dr. Aaberg practices at Retina Specialists of Michigan in Grand Rapids, Michigan.

Dr. Aaberg's NPI, 1194753186, was assigned on June 29, 2006. Dr. Aaberg graduated from University of Wisconsin-Madison in 1991. Dr. Aaberg holds Michigan license 4301077476.

Dr. Aaberg's primary practice is Retina Specialists of Michigan, at 5030 Cascade SE Rd, Grand Rapids, MI 49546 in Kent County. The practice phone is (616) 954-2020.

Dr. Aaberg's primary practice is Retina Specialists of Michigan in Grand Rapids, Michigan. Dmand AI also links Dr. Aaberg to 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Aaberg practices. Vendor and product names are available with a free account.

Retina specialist is Dr. Aaberg's primary specialty in the NPI Registry, under taxonomy code 207WX0107X. Dr. Aaberg is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Aaberg's licenses on file in 5 states: Michigan, California, Florida, Georgia and Wisconsin.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, cold sores or genital herpes, dry eye, eye infection or inflammation, eyelid inflammation and glaucoma among the conditions Dr. Aaberg treats.

CMS data shows 1,102 Medicare services from Dr. Aaberg across 8 procedure codes in 2024, for 168 Medicare patients. Medicare paid $183,306 for them. Every service was in an office.

CMS counts 168 Medicare patients who saw Dr. Aaberg in 2024. The largest group is 65 to 74, with 62 patients. 74% of them have high blood pressure, and 72% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.41, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Aaberg's median patient age at 73, with 57% women.

In 2024, Dr. Aaberg wrote 333 Medicare Part D claims for 78 patients. 64% of them were for generic drugs. CMS names the drug for 243 of them, across 9 drugs with 11 or more claims each, at $13,037 in total drug cost. In 2023, CMS named 291 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Aaberg for performance year 2024, reported as part of a group. Dr. Aaberg accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 108 papers to Dr. Aaberg, published from 2008 to 2022. 2012 was the busiest year, with 2. The most frequent topics are Visual Acuity, Retinal Detachment and Retinal Diseases. Dr. Aaberg has published most often in Am J Ophthalmol. Dr. Aaberg's most frequent co-authors are Antonio Capone, MD, Thomas M. Aaberg, MD and Chris Sheldon Bergstrom, MD.

Dmand AI links Dr. Aaberg to 1 clinical trial. Conditions studied include Geographic Atrophy and Macular Degeneration.

CMS Open Payments shows 194 general payments to Dr. Aaberg from 33 drug and device companies from 2016 to 2025. Royalties and licenses make up the largest share, 33% of the total. Alcon Research Ltd paid the most, $25,449. It also lists 46 research payments totaling $347,609 from 2016 to 2020.

Dmand AI lists 8 awards for Dr. Aaberg, most recently The Vision in Action Award in 2013.

Dr. Aaberg graduated from University of Wisconsin-Madison in 1991. Dr. Aaberg is a member of AAO.

Dr. Aaberg is in network with 14 carriers, including Aetna, Elevance and Health Alliance Plan. HMO plans come from the most carriers, 11. Check the plan with the practice before a visit.